{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T13:14:47Z","timestamp":1768742087044,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Thymic epithelial tumors (TETs) are rare neoplasms often associated with immune-related disorders. Patients with Good\u2019s syndrome (GS), an adult-acquired TET-related immunodeficiency, are at a high risk of mortality due to infectious diseases. This study aims to examine COVID-19 occurrence and severity in TET patients, with or without GS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Clinical records of TET patients referred to the Regional Coordinating Center for Rare Tumors of Campania Region were retrospectively collected. During the observation period, elapsing from March 2020 to April 2023, the following data were collected: occurrence of SARS-CoV-2 infection; COVID-19 severity, according to the National Institute of Health (NIH) illness categories; COVID-19 treatment. COVID-19 occurrence and severity were assessed in the overall population and correlated with the presence of GS and\/or other immune-related dysregulations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Overall, 47 TET patients were included in the study; 27 of these (57.4%) had GS. All participants had received a full cycle of mRNA vaccine for SARS-CoV2., Thirty-one patients (66.0%) experienced COVID-19, of whom 18 (58.0%) had previously received a diagnosis of GS. No significant association of GS and\/or other immune-related dysregulations with SARS-CoV-2 infection occurrence was detected (Fisher\u2019s exact test <jats:italic>p<\/jats:italic>\u2009=\u20091 and <jats:italic>p<\/jats:italic>\u2009=\u20090.3587, respectively). Among patients with GS, 8 (45.0%) reported a COVID-19 severity score of \u2265\u20093; whereas, only 1 of the 13 patients without GS (7.7%) had a severity score of \u2265\u20093. The correlation between presence of GS and COVID-19 severity (score 1 or 2 vs.\u2009\u2265\u20093) was statistically significant (<jats:italic>p<\/jats:italic>\u2009=\u20090.0448). No statistically significant association between COVID-19 severity and other immune-related syndromes were found (<jats:italic>p<\/jats:italic>\u2009=\u20091). Of note, all the hospitalized patients for NIH 4 and 5 COVID-19 had GS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our data suggest that TET patients, especially those with GS, require a careful multidisciplinary monitoring for SARS-CoV-2 infection, in order to establish tailored treatments and prophylactic protocols.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-024-12405-4","type":"journal-article","created":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T14:03:21Z","timestamp":1718805801000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["COVID-19 in patients with thymic epithelial tumors with or without Good\u2019s syndrome: a single-center retrospective study"],"prefix":"10.1186","volume":"24","author":[{"given":"Erica","family":"Pietroluongo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annarita","family":"Peddio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"De Placido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"Tortora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Ottaviano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Gelzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo","family":"Cernera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Foggia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio Riccardo","family":"Buonomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biagio","family":"Pinchera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela","family":"Zappulo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Mercinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Letizia","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Sardanelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulio","family":"Viceconte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Scotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Schiano Moriello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Servetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmine","family":"De Angelis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grazia","family":"Arpino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovannella","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabino","family":"De Placido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Castaldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Giuliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,19]]},"reference":[{"issue":"4","key":"12405_CR1","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/1759-7714.13760","volume":"12","author":"P Rioja","year":"2021","unstructured":"Rioja P, Ruiz R, Galvez-Nino M, Lozano S, Valdiviezo N, Olivera M, Cabero O, Guillen ME, De La Guerra A, Amorin E, Barrionuevo C, Mas L. Epidemiology of thymic epithelial tumors: 22-years experience from a single-institution. Thorac Cancer. 2021;12(4):420\u20135. Epub 2020 Dec 23. PMID: 33356008; PMCID: PMC7882391.","journal-title":"Thorac Cancer"},{"issue":"1","key":"12405_CR2","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jtcvs.2019.11.052","volume":"160","author":"J Zhao","year":"2020","unstructured":"Zhao J, Bhatnagar V, Ding L, Atay SM, David EA, McFadden PM, Stamnes S, Lechtholz-Zey E, Wightman SC, Detterbeck FC, Kim AW. A systematic review of paraneoplastic syndromes associated with thymoma: treatment modalities, recurrence, and outcomes in resected cases. J Thorac Cardiovasc Surg. 2020;160(1):306\u2013e31414. Epub 2019 Dec 2. PMID: 31982129.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"12405_CR3","doi-asserted-by":"publisher","first-page":"908453","DOI":"10.3389\/fimmu.2022.908453","volume":"13","author":"AM Malfitano","year":"2022","unstructured":"Malfitano AM, D\u2019Esposito V, De Placido P, Tortora M, Ottaviano M, Pietroluongo E, Morra R, Mucci B, Napolitano F, Montella L, Giuliano M, De Placido S, Terracciano D, Palmieri G, Formisano P. Immunological signature of patients with thymic epithelial tumors and good syndrome. Front Immunol. 2022;13:908453. https:\/\/doi.org\/10.3389\/fimmu.2022.908453.","journal-title":"Front Immunol"},{"issue":"1","key":"12405_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/jcp.56.1.12","volume":"56","author":"P Kelleher","year":"2003","unstructured":"Kelleher P, Misbah SA. What is Good\u2019s syndrome? Immunological abnormalities in patients with thymoma. J Clin Pathol. 2003;56(1):12\u20136. https:\/\/doi.org\/10.1136\/jcp.56.1.12. PMID: 12499426; PMCID: PMC1769851.","journal-title":"J Clin Pathol"},{"issue":"8","key":"12405_CR5","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1182\/blood-2002-08-2638","volume":"101","author":"AM Masci","year":"2003","unstructured":"Masci AM, Palmieri G, Vitiello L, Montella L, Perna F, Orlandi P, Abbate G, Zappacosta S, De Palma R, Racioppi L. Clonal expansion of CD8\u2009+\u2009BV8 T lymphocytes in bone marrow characterizes thymoma-associated B lymphopenia. Blood. 2003;101(8):3106\u20138. https:\/\/doi.org\/10.1182\/blood-2002-08-2638. Epub 2002 Dec 19. PMID: 12515721.","journal-title":"Blood"},{"issue":"6","key":"12405_CR6","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.3390\/biomedicines11061605","volume":"11","author":"R Paganelli","year":"2023","unstructured":"Paganelli R, Di Lizia M, D\u2019Urbano M, Gatta A, Paganelli A, Amerio P, Parronchi P. Insights from a case of Good\u2019s syndrome (immunodeficiency with Thymoma). Biomedicines. 2023;11(6):1605. https:\/\/doi.org\/10.3390\/biomedicines11061605. PMID: 37371700; PMCID: PMC10296089.","journal-title":"Biomedicines"},{"issue":"2","key":"12405_CR7","first-page":"437","volume":"48","author":"AR Hayward","year":"1982","unstructured":"Hayward AR, Paolucci P, Webster AD, Kohler P. Pre-B cell suppression by thymoma patient lymphocytes. Clin Exp Immunol. 1982;48(2):437\u201342. PMID: 6980746; PMCID: PMC1536454.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"12405_CR8","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/cei.13216","volume":"195","author":"M Zaman","year":"2019","unstructured":"Zaman M, Huissoon A, Buckland M, Patel S, Alachkar H, Edgar JD, Thomas M, Arumugakani G, Baxendale H, Burns S, Williams AP, Jolles S, Herriot R, Sargur RB, Arkwright PD. Clinical and laboratory features of seventy-eight UK patients with Good\u2019s syndrome (thymoma and hypogammaglobulinaemia). Clin Exp Immunol. 2019;195(1):132\u20138. https:\/\/doi.org\/10.1111\/cei.13216. Epub 2018 Oct 21. PMID: 30216434; PMCID: PMC6300645.","journal-title":"Clin Exp Immunol"},{"issue":"47","key":"12405_CR9","doi-asserted-by":"publisher","first-page":"e2090","DOI":"10.1097\/MD.0000000000002090","volume":"94","author":"X Sun","year":"2015","unstructured":"Sun X, Shi J, Wang M, Xu K, Xiao Y. Good\u2019s syndrome patients hospitalized for infections: a single-Center Retrospective Study. Med (Baltim). 2015;94(47):e2090. https:\/\/doi.org\/10.1097\/MD.0000000000002090. PMID: 26632723; PMCID: PMC5058992.","journal-title":"Med (Baltim)"},{"key":"12405_CR10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.21037\/med-21-47","volume":"7","author":"E Pietroluongo","year":"2022","unstructured":"Pietroluongo E, De Placido P, Picozzi F, Morra R, Tortora M, Del Deo V, Montella L, Palmieri G, Buonomo AR, De Placido S, Gentile I, Giuliano M. Multidisciplinary approach for rare thoracic tumors during COVID-19 pandemic. Mediastinum (Hong Kong China). 2022;7:8. https:\/\/doi.org\/10.21037\/med-21-47.","journal-title":"Mediastinum (Hong Kong China)"},{"key":"12405_CR11","unstructured":"Aiom. Raccomandazioni 2020 su tumori epiteliali del timo (TET). Italian Association of Medical Oncology (AIOM) Thymic epithelial tumors (TET) recommendations 2020. https:\/\/www.aiom.it\/raccomandazioni-2020-su-tumori-epiteliali-del-timo-tet\/. Accessed December 13, 2022."},{"key":"12405_CR12","unstructured":"https:\/\/www.covid19treatmentguidelines.nih.gov\/."},{"key":"12405_CR13","unstructured":"https:\/\/www.aifa.gov.it\/vaccini-covid-19."},{"key":"12405_CR14","unstructured":"https:\/\/www.aifa.gov.it\/uso-degli-anticorpi-monoclonali."},{"key":"12405_CR15","unstructured":"https:\/\/www.aifa.gov.it\/uso-degli-antivirali-orali-per-covid-19."},{"key":"12405_CR16","doi-asserted-by":"publisher","first-page":"e000885","DOI":"10.1136\/esmoopen-2020-000885","volume":"5","author":"G Arpino","year":"2020","unstructured":"Arpino G, et al. Optimising triage procedures for patients with cancer needing active anticancer treatment in the COVID-19 era. ESMO open vol. 2020;5:e000885. https:\/\/doi.org\/10.1136\/esmoopen-2020-000885.","journal-title":"ESMO open vol"},{"key":"12405_CR17","doi-asserted-by":"publisher","unstructured":"Shi Y, Wang C. When the Good Syndrome Goes Bad: A Systematic Literature Review. Frontiers in immunology vol. 12 679556. 25 May. 2021, https:\/\/doi.org\/10.3389\/fimmu.2021.679556.","DOI":"10.3389\/fimmu.2021.679556"},{"key":"12405_CR18","doi-asserted-by":"publisher","first-page":"951026","DOI":"10.3389\/fonc.2022.951026","volume":"12","author":"P De Placido","year":"2022","unstructured":"De Placido P, Pietroluongo E, De Angelis C, Tafuro M, Barraco C, Giannatiempo R, Buonaiuto R, Schettini F, Iervolino A, Vozzella EA, Giuliano M, Bianco R, Arpino G. Safety and immunogenicity of the COVID-19 vaccine BNT162b2 for patients with breast and gynecological cancer on active anticancer therapy: results of a prospective observational study. Front Oncol. 2022;12:951026. https:\/\/doi.org\/10.3389\/fonc.2022.951026.","journal-title":"Front Oncol"},{"key":"12405_CR19","doi-asserted-by":"publisher","unstructured":"Pietroluongo E, De Placido P, Tortora M, Martinelli C, Viggiano A, Saponaro MR, Caltavituro A, Buonaiuto R, Morra R, Ottaviano M, Del Deo V, Cernera G, Gelzo M, Malfitano AM, Di Tolla MF, De Angelis C, Arpino G, Terracciano D ... Giuliano M. Impaired seroconversion after severe acute respiratory syndrome coronavirus 2 mRNA vaccine in patients with thymic epithelial tumors. J Thorac Oncol 2023;18(10):1399\u2013407. https:\/\/doi.org\/10.1016\/j.jtho.2023.06.015.","DOI":"10.1016\/j.jtho.2023.06.015"},{"key":"12405_CR20","doi-asserted-by":"publisher","first-page":"1233056","DOI":"10.3389\/fimmu.2023.1233056","volume":"14","author":"G Cernera","year":"2023","unstructured":"Cernera G, Gelzo M, De Placido P, Ottaviano M, Pietroluongo E, Raia M, Scalia G, Tortora M, Castaldo G, Formisano P, Palmieri G, Giuliano M. Immunocytometric analysis of patients with thymic epithelial tumors revealed that COVID-19 vaccine booster strongly enhanced the immune response. Front Immunol. 2023;14:1233056. https:\/\/doi.org\/10.3389\/fimmu.2023.1233056.","journal-title":"Front Immunol"},{"key":"12405_CR21","doi-asserted-by":"publisher","first-page":"100068","DOI":"10.1016\/j.gloepi.2021.100068","volume":"3","author":"HH Ayoub","year":"2021","unstructured":"Ayoub HH, Mumtaz GR, Seedat S, Makhoul M, Chemaitelly H, Abu-Raddad LJ. Estimates of global SARS-CoV-2 infection exposure, infection morbidity, and infection mortality rates in 2020. Glob Epidemiol. 2021;3:100068. https:\/\/doi.org\/10.1016\/j.gloepi.2021.100068. Epub 2021 Nov 23. PMID: 34841244; PMCID: PMC8609676.","journal-title":"Glob Epidemiol"},{"issue":"2","key":"12405_CR22","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1093\/cid\/ciaa863","volume":"72","author":"M Fung","year":"2021","unstructured":"Fung M, Babik JM. COVID-19 in immunocompromised hosts: what we know so far. Clin Infect Dis. 2021;72(2):340\u201350. https:\/\/doi.org\/10.1093\/cid\/ciaa863. PMID: 33501974; PMCID: PMC7337668.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"12405_CR23","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.3390\/cancers12113266","volume":"12","author":"G Seth","year":"2020","unstructured":"Seth G, Sethi S, Bhattarai S, Saini G, Singh CB, Aneja R. SARS-CoV-2 infection in Cancer patients: effects on Disease outcomes and Patient Prognosis. Cancers (Basel). 2020;12(11):3266. https:\/\/doi.org\/10.3390\/cancers12113266. PMID: 33167313; PMCID: PMC7694326.","journal-title":"Cancers (Basel)"},{"key":"12405_CR24","doi-asserted-by":"crossref","unstructured":"Milito C, Firinu D, Bez P, Villa A, Punziano A, Lagnese G, Costanzo G, van Leeuwen LPM, Piazza B, Deiana CM, d\u2019Ippolito G, Del Giacco SR, Rattazzi M, Spadaro G, Quinti I, Scarpa R, Dalm VASH, Cinetto F. A beacon in the dark: COVID-19 course in CVID patients from two European countries: different approaches, similar outcomes. Front Immunol. 2023 Feb.","DOI":"10.3389\/fimmu.2023.1093385"},{"key":"12405_CR25","doi-asserted-by":"publisher","first-page":"109097","DOI":"10.1016\/j.clim.2022.109097","volume":"243","author":"E Drzymalla","year":"2022","unstructured":"Drzymalla E, Green RF, Knuth M, Khoury MJ, Dotson WD, Gundlapalli A. COVID-19-related health outcomes in people with primary immunodeficiency: a systematic review. Clin Immunol. 2022;243:109097. https:\/\/doi.org\/10.1016\/j.clim.2022.109097. Epub 2022 Aug 13. PMID: 35973637; PMCID: PMC9375253.","journal-title":"Clin Immunol"},{"key":"12405_CR26","doi-asserted-by":"crossref","unstructured":"Whisenant, J. G., Baena, J., Cortellini, A., Huang, L. C., Lo Russo, G., Porcu, L.,Wong, S. K., Bestvina, C. M., Hellmann, M. D., Roca, E., Rizvi, H., Monnet, I., Boudjemaa,A., Rogado, J., Pasello, G., Leighl, N. B., Arrieta, O., Aujayeb, A., Batra, U., Azzam,A. Y., \u2026 TERAVOLT study group (2022). A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry. Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer, 17(5), 661\u2013674. https:\/\/doi.org\/10.1016\/j.jtho.2021.12.015.","DOI":"10.1016\/j.jtho.2021.12.015"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12405-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-12405-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12405-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T02:01:31Z","timestamp":1718848891000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-12405-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,19]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["12405"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-12405-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,19]]},"assertion":[{"value":"23 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the University of Naples Federico II (approval n.76.21). Informed consents were signed by all patients included in the study before starting data collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"748"}}